Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation
- 22 February 2012
- journal article
- clinical trial
- Published by Wiley in British Journal of Pharmacology
- Vol. 165 (6) , 1904-1913
- https://doi.org/10.1111/j.1476-5381.2011.01689.x
Abstract
BACKGROUND AND PURPOSE Prolonged wakefulness impairs sustained vigilant attention, measured with the psychomotor vigilance task (PVT), and induces a compensatory increase in sleep intensity in recovery sleep, quantified by slow-wave activity (SWA) in the sleep electroencephalogram (EEG). These effects of sleep deprivation are counteracted by the adenosine receptor antagonist caffeine, implying involvement of the adenosine neuromodulator/receptor system. To examine a role for adenosine A2A receptors, we investigated whether variation of the A2A receptor gene (ADORA2A) modified effects of caffeine on PVT and SWA after sleep deprivation. EXPERIMENTAL APPROACH A haplotype analysis of eight single-nucleotide polymorphisms of ADORA2A was performed in 82 volunteers. In 45 young men carrying five different allele combinations, we investigated the effects of prolonged waking and 2 × 200 mg caffeine or 2 × 100 mg modafinil on psychomotor vigilance, sleepiness, and the waking and sleep EEG. KEY RESULTS Throughout extended wakefulness, the carriers of haplotype HT4 performed faster on the PVT than carriers of non-HT4 haplotype alleles. In haplotype HT4, caffeine failed to counteract the waking-induced impairment of PVT performance and the rebound of SWA in recovery sleep. However, caffeine was effective in non-HT4 allele carriers, and modafinil reduced the consequences of prolonged waking, independently of ADORA2A haplotype. CONCLUSIONS AND IMPLICATIONS Common genetic variation of ADORA2A is an important determinant of psychomotor vigilance in rested and sleep-deprived state. It also modulates individual responses to caffeine after sleep deprivation. These findings demonstrate a role for adenosine A2A receptors in the effects of prolonged wakefulness on vigilant attention and the sleep EEG.Keywords
This publication has 45 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology, 2011
- Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine ConsumptionNeuropsychopharmacology, 2010
- Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced AnxietyNeuropsychopharmacology, 2008
- Modafinil: A Review of Neurochemical Actions and Effects on CognitionNeuropsychopharmacology, 2007
- Adenosinergic Mechanisms Contribute to Individual Differences in Sleep Deprivation-Induced Changes in Neurobehavioral Function and Brain Rhythmic ActivityJournal of Neuroscience, 2006
- Caffeine Attenuates Waking and Sleep Electroencephalographic Markers of Sleep Homeostasis in HumansNeuropsychopharmacology, 2004
- Evidence for Genetic Linkage Between a Polymorphism in the Adenosine 2A Receptor and Panic DisorderNeuropsychopharmacology, 2003
- Proposed supplements and amendments to ‘A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects’, the Rechtschaffen & Kales (1968) standardPsychiatry and Clinical Neurosciences, 2001
- The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A2A receptorsBritish Journal of Pharmacology, 2000
- Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of diseaseMolecular Psychiatry, 1998